top of page
images.jpg

DOST Cavite presents programs

at Cavite forums 2026

DOST Cavite participated in two simultaneous activities organized by the Office of the Provincial Cooperative Development Officer (OPCDO) Cavite, namely the Cavite Agribusiness Forum and the Financial Dialogue and Credit Matching Activity, held on Nov. 13 at the New Cavite Government Center.
 

1-year-old boy dies in Carmona house fire

​A one-year-old boy died on Nov. 13 after a fire destroyed his family’s house in Carmona City, Cavite.
The Police Regional Office 4A reported on Nov. 14 that the fire broke out in Barangay Milagrosa at around 9:45 p.m.
According to the police, the boy’s mother had left him under the care of her two other young children while she visited a neighbor’s house before dinner.
While their mother was away, the two children reportedly lit a candle and placed it inside the room where their younger brother was sleeping.
The two then went outside to play, leaving the boy alone inside the room with the lit candle. Several hours later, a fire broke out inside the house. Firefighters immediately responded to the scene and discovered the boy’s burned body after putting out the fire at around 10:50 p.m.
The police report stated that the room where the victim had been sleeping reportedly contained several flammable materials and other items that could easily catch fire. However, authorities did not specify what these materials were.


 

Breakthrough treatment leads to type 2 diabetes remission for over half of patients

Pairing a strict diet with a real exercise routine may be one of the sharpest tools available for pushing type 2 diabetes into remission in younger adults.
A fresh clinical trial put that idea to the test. More than half the people assigned to an intensive lifestyle program hit remission inside six months. On standard care, only 4% managed the same feat.
Those results landed at the Annual Meeting of the European Association for the Study of Diabetes (EASD). They also appeared in The Lancet Regional Health Americas.
The takeaway is striking. A low-calorie diet combined with regular movement could bend the trajectory of early-onset type 2 diabetes, or EOT2D, which means diagnosis before age 45.
Professor Kaberi Dasgupta led the effort. She heads the Division of General Internal Medicine at McGill University in Montreal, Canada.
She worked alongside Professor Thomas Yates of the University of Leicester in the UK, plus their colleagues.
Diabetes that shows up young tends to bite harder.
Patients with EOT2D usually watch their blood sugar slip out of control faster. Complications arrive earlier in life. Life expectancy shrinks compared with people diagnosed later.
Earlier work had already shown something promising. Very low-calorie diets, or LEDs, can drag glucose down far enough that some people reach remission without any medication.
Remission carries a specific meaning. Blood sugar drops below the diagnostic threshold and stays there, unaided by glucose-lowering drugs. It does not guarantee the disease is gone forever.
The researchers pushed further. Could structured exercise sharpen this approach even more?
Movement does more than trim glucose. It lifts fitness, guards muscle while weight falls, boosts heart function and blunts insulin resistance.
So the team asked a clean question. Would a low-calorie diet plus supervised exercise produce remission by week 24 better than ordinary medical care?
Their randomized clinical trial unfolded across three research centers in England and Canada. These were tied to the University of Leicester in the UK, McGill University in Montreal, and the University of Alberta in Edmonton.
Enrollment covered adults between 18 and 45. All had early-onset type 2 diabetes plus obesity, and none took insulin.
The study ran open-label. Everyone knew which treatment they were getting, though the assessment of the primary outcome stayed blinded.
One group simply carried on with usual care.
The other followed a demanding regimen. Daily calories dropped to 800-900. Supervised aerobic and resistance sessions came twice weekly, with one extra solo workout each week through week 12.
From weeks 13 to 24, the diet shifted toward holding the lost weight steady. Exercise continued independently.
Success was measured by remission at 24 weeks. To qualify, someone needed HbA1c under 6.5%, equal to 48 mmol/mol, and no glucose-lowering medication for at least 12 weeks.
HbA1c is a blood marker that averages glucose over roughly three months.
Every person randomized got counted in the analysis. Where remission data went missing, the team took the conservative route and scored those cases as failures.
They also tracked cardiovascular fitness, body composition and heart structure.
At the outset of the intensive arm, participants stopped their blood sugar and blood pressure medications under medical supervision, except where albuminuria was present.
Albuminuria signals a protein called albumin leaking into urine, often a warning sign of kidney damage.
The tight diet supplied 800-900 calories daily, split into 30% protein, 50% carbohydrate and 20% fat.
People were told to drink at least two liters of calorie-free fluids every day. A fiber-based laxative stood ready whenever it was needed.
For the opening fortnight, every meal came from specially formulated Optifast products.
Weeks three through 12 held the same calorie ceiling but loosened food choices. Optifast served participants in the UK; ProtiDiet covered Canada.
That second phase permitted one conventional meal per day. Daily targets included 60-90 grams of protein from all sources, one portion of fruit and two portions of non-starchy vegetables.
Past week 12, the mission changed. Rapid shedding gave way to keeping the pounds off.
Recruitment ran from September 24, 2021 to June 6, 2025. Over that stretch, 96 participants were enrolled and randomized: 40 from the UK, 56 from Canada.
Fifty people drew the intensive intervention, 46 the standard care. Within the intervention arm sat 24 women and 26 men; the control arm held 21 women and 25 men. Average age came to 38 years, average BMI to 35.2 kg/m2.
Of everyone signed up, 86 completed the final assessments, a 90% retention rate.
The contrast between groups turned out dramatic. By week 24, 27 of the 50 dieters-and-exercisers had reached remission, or 54%.
Standard care delivered just two remissions among 46 participants, roughly 4%.
Once relevant statistical factors were factored in, intensive-program members stood 21 times likelier to achieve remission than those on usual care. Weight loss told a similar story. Among 47 intervention participants with usable weight figures, average body weight slid from 100.7 kg to 92.3 kg, a drop of 8.4 kg across 24 weeks.
The 43 control participants with data began at 103.2 kg and shed a mere 1.2 kg, finishing at 102.0 kg.
After adjustment, the intervention group averaged 7.5 kg more loss than controls. Critically, 6.6 kg of that edge was pure fat, showing most of the gap came from trimming body fat.
No severe adverse events surfaced during the trial. Side effects, however, clustered heavily in the intensive-diet camp.
Forty-three of 50 intervention participants logged at least one adverse event, against six of 46 on standard care.
Troubles mostly flared early in the restrictive phase: constipation, headaches, dizziness and fatigue. In general, these faded.
The investigators read the findings as proof that diet plus exercise can deliver gains well beyond glucose numbers.
"Our findings demonstrate the feasibility and efficacy of combining structured aerobic and resistance exercise with a low energy diet in early-onset type 2 diabetes," the authors wrote, backing its potential to bring substantial, whole-person health and well-being benefits alongside diabetes remission.
They added that their remission rates sit at the upper end of what similar-length trials have reported. That reinforces structured lifestyle interventions as engines of clinically meaningful remission, while proving for the first time such results are reachable in a multi-ethnic population with early-onset type 2 diabetes through a combined low-energy diet and structured exercise plan.
One design choice deserves special attention: defending muscle during fast weight loss.
Most people who finish a weight-loss program eventually regain part or all of it. That reality looms large when very low-calorie diets drive diabetes remission.
Cutting calories alone strips away fat and fat-free mass alike, muscle included. Some evidence hints that when weight returns, the body rebuilds proportionally more fat than lean tissue.
Cycle that repeatedly and muscle quietly erodes, nudging up the risk of sarcopenia, the condition of dwindling muscle mass and strength.
To head this off, resistance training was woven into the heaviest stretch of weight loss. The results hint that heavy fat loss and muscle preservation can coexist, possibly making the method kinder to long-term metabolic health.
"Our RESET for Remission study targeted muscle during the intensive weight loss phase through resistance training, and our findings indicate fat-free mass and muscle preservation is achievable with rapid weight loss," they stated. Holding onto muscle during remission-focused weight loss, they noted, may carry real consequences for long-term metabolic health, physical function and disease trajectory, all needing longer-term study.
These insights grow more urgent as type 2 diabetes spreads through younger adults around the globe.
Anyone diagnosed early faces more years bathed in elevated blood sugar, inflating lifetime odds of cardiovascular disease and other complications. Effective early remission could therefore pay enormous health dividends.
The team stressed that their intervention did more than nudge glucose downward. It stripped fat while shielding muscle, upgraded muscle quality and physical performance, backed cardiovascular health and lifted participants' own sense of well-being.
They also floated that this strategy might matter especially for people planning a pregnancy or who could become pregnant.
Still, the researchers urged patience. Longer studies must confirm whether the wins endure, particularly how well people hold their weight loss, muscle mass and remission once they leave close clinical monitoring behind.
"By focusing specifically on early-onset type 2 diabetes, our trial addresses a growing clinical population, characterized by elevated cardiovascular disease risk, greater cumulative complication burden, and poor long-term outcomes," the authors concluded.
In summary, they said, RESET for Remission showed that in early-onset type 2 diabetes, pairing structured aerobic and resistance exercise with a low-calorie diet yields high remission rates, melts fat while preserving muscle, improves muscle quality and function, strengthens cardiovascular health and produces meaningful patient-reported gains. With EOT2D rising worldwide, the findings point to a chance to rethink treatment paradigms and scale integrated diet-and-exercise programs, an approach they believe may prove especially valuable for those seeking or with potential for pregnancy, warranting longer-term study in real-world settings.

CONTACT US

​Email:            barcogener@gmail.com
Address:   
    Block 13 Lot 1 Liwayway Homes Subdivision,                                          Anabu 1-C, City of Imus, Cavite

Cellphone:    0917 949 6918

GET UPDATED

  • Instagram
  • Facebook
  • Twitter
bottom of page